Medicamen Biotech consolidated net profit declines 1.40% in the June 2026 quarter

Sales rise 11.29% to Rs 47.90 crore

Net profit of Medicamen Biotech declined 1.40% to Rs 2.12 crore in the quarter ended June 2026 as against Rs 2.15 crore during the previous quarter ended June 2025. Sales rose 11.29% to Rs 47.90 crore in the quarter ended June 2026 as against Rs 43.04 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	47.90	43.04	11
OPM %	9.04	10.73	-
PBDT	4.36	3.93	11
PBT	2.57	2.13	21
NP	2.12	2.15	-1

Powered by Capital Market - Live News